IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder

 
 
 

Dr. Jeff Ratliff talks with Dr. Ron Postuma about the clinical features associated with IGLON5 positivity, emphasizing the implications for practitioners in diagnosing and treating sleep and movement disorders.

 
Previous
Previous

Dr. Wolfgang Singer Named Professor of Neurology: Advancing Autonomic Research at Mayo Clinic

Next
Next

Post-Mortem Neuropathology of Idiopathic RBD: A Case Series